Literature DB >> 30535831

Pathophysiology and Treatment of Canavan Disease.

David Pleasure1,2, Fuzheng Guo3, Olga Chechneva3, Peter Bannerman3, Jennifer McDonough4, Travis Burns3, Yan Wang3, Vanessa Hull3.   

Abstract

Entities:  

Keywords:  Aspartoacylase (encoded by ASPA); Canavan disease; Gene therapy; N-acetyl-L-aspartate (NAA); N-acetyltransferase 8-like (encoded by Nat8l); NaDC3 (encoded by Slc13a3); Vacuolar (“spongiform”) leukodystrophy

Mesh：

Substances：

Year:  2018        PMID： 30535831     DOI： 10.1007/s11064-018-2693-6

Source DB:  PubMed          Journal:  Neurochem Res        ISSN： 0364-3190            Impact factor:   3.996


× No keyword cloud information.
  42 in total

1.  Panglial gap junctional communication is essential for maintenance of myelin in the CNS.

Authors:  Oliver Tress; Marta Maglione; Dennis May; Tatjyana Pivneva; Nadine Richter; Julia Seyfarth; Sonja Binder; Armin Zlomuzica; Gerald Seifert; Martin Theis; Ekrem Dere; Helmut Kettenmann; Klaus Willecke
Journal:  J Neurosci       Date:  2012-05-30       Impact factor: 6.167

2.  Transport characteristics of N-acetyl-L-aspartate in rat astrocytes: involvement of sodium-coupled high-affinity carboxylate transporter NaC3/NaDC3-mediated transport system.

Authors:  Takuya Fujita; Hiromi Katsukawa; Etsuo Yodoya; Miyuki Wada; Ayumi Shimada; Naoki Okada; Akira Yamamoto; Vadivel Ganapathy
Journal:  J Neurochem       Date:  2005-05       Impact factor: 5.372

Review 3.  Advances in understanding the peptide neurotransmitter NAAG and appearance of a new member of the NAAG neuropeptide family.

Authors:  Joseph H Neale; Rafal T Olszewski; Daiying Zuo; Karolina J Janczura; Caterina P Profaci; Kaleen M Lavin; John C Madore; Tomasz Bzdega
Journal:  J Neurochem       Date:  2011-07-01       Impact factor: 5.372

4.  Long-term follow-up after gene therapy for canavan disease.

Authors:  Paola Leone; David Shera; Scott W J McPhee; Jeremy S Francis; Edwin H Kolodny; Larissa T Bilaniuk; Dah-Jyuu Wang; Mitra Assadi; Olga Goldfarb; H Warren Goldman; Andrew Freese; Deborah Young; Matthew J During; R Jude Samulski; Christopher G Janson
Journal:  Sci Transl Med       Date:  2012-12-19       Impact factor: 17.956

5.  A single intravenous rAAV injection as late as P20 achieves efficacious and sustained CNS Gene therapy in Canavan mice.

Authors:  Seemin Seher Ahmed; Huapeng Li; Chunyan Cao; Elif M Sikoglu; Andrew R Denninger; Qin Su; Samuel Eaton; Ana A Liso Navarro; Jun Xie; Sylvia Szucs; Hongwei Zhang; Constance Moore; Daniel A Kirschner; Thomas N Seyfried; Terence R Flotte; Reuben Matalon; Guangping Gao
Journal:  Mol Ther       Date:  2013-07-02       Impact factor: 11.454

6.  N-acetylaspartate supports the energetic demands of developmental myelination via oligodendroglial aspartoacylase.

Authors:  Jeremy S Francis; Ireneusz Wojtas; Vladimir Markov; Steven J Gray; Thomas J McCown; R Jude Samulski; Larissa T Bilaniuk; Dah-Jyuu Wang; Darryl C De Vivo; Christopher G Janson; Paola Leone
Journal:  Neurobiol Dis       Date:  2016-10-04       Impact factor: 5.996

7.  Lithium citrate reduces excessive intra-cerebral N-acetyl aspartate in Canavan disease.

Authors:  Mitra Assadi; Christopher Janson; Dah-Jyuu Wang; Olga Goldfarb; Neeti Suri; Larissa Bilaniuk; Paola Leone
Journal:  Eur J Paediatr Neurol       Date:  2010-01-19       Impact factor: 3.140

8.  Clinically Distinct Phenotypes of Canavan Disease Correlate with Residual Aspartoacylase Enzyme Activity.

Authors:  Marisa I Mendes; Desirée Ec Smith; Ana Pop; Pascal Lennertz; Matilde R Fernandez Ojeda; Warsha A Kanhai; Silvy Jm van Dooren; Yair Anikster; Ivo Barić; Caroline Boelen; Jaime Campistol; Lonneke de Boer; Ariana Kariminejad; Hulya Kayserili; Agathe Roubertie; Krijn T Verbruggen; Christine Vianey-Saban; Monique Williams; Gajja S Salomons
Journal:  Hum Mutat       Date:  2017-02-14       Impact factor: 4.878

9.  The effect of N-acetyl-aspartyl-glutamate and N-acetyl-aspartate on white matter oligodendrocytes.

Authors:  Karolina Kolodziejczyk; Nicola B Hamilton; Anna Wade; Ragnhildur Káradóttir; David Attwell
Journal:  Brain       Date:  2009-04-21       Impact factor: 13.501

10.  Extracellular N-Acetylaspartate in Human Traumatic Brain Injury.

Authors:  Richard J Shannon; Susan van der Heide; Eleanor L Carter; Ibrahim Jalloh; David K Menon; Peter J Hutchinson; Keri L H Carpenter
Journal:  J Neurotrauma       Date:  2015-08-14       Impact factor: 5.269
View more
  5 in total

1.  Therapeutic development for Canavan disease using patient iPSCs introduced with the wild-type ASPA gene.

Authors:  Jianfei Chao; Lizhao Feng; Peng Ye; Xianwei Chen; Qi Cui; Guihua Sun; Tao Zhou; E Tian; Wendong Li; Weidong Hu; Arthur D Riggs; Reuben Matalon; Yanhong Shi
Journal:  iScience       Date:  2022-05-11

2.  The natural history of Canavan disease: 23 new cases and comparison with patients from literature.

Authors:  Annette Bley; Jonas Denecke; Alfried Kohlschütter; Gerhard Schön; Sandra Hischke; Philipp Guder; Tatjana Bierhals; Heather Lau; Maja Hempel; Florian S Eichler
Journal:  Orphanet J Rare Dis       Date:  2021-05-19       Impact factor: 4.123

3.  Genetic testing of leukodystrophies unraveling extensive heterogeneity in a large cohort and report of five common diseases and 38 novel variants.

Authors:  Nejat Mahdieh; Mahdieh Soveizi; Ali Reza Tavasoli; Ali Rabbani; Mahmoud Reza Ashrafi; Alfried Kohlschütter; Bahareh Rabbani
Journal:  Sci Rep       Date:  2021-02-05       Impact factor: 4.379

Review 4.  Function of Akkermansia muciniphila in Obesity: Interactions With Lipid Metabolism, Immune Response and Gut Systems.

Authors:  Yu Xu; Ning Wang; Hor-Yue Tan; Sha Li; Cheng Zhang; Yibin Feng
Journal:  Front Microbiol       Date:  2020-02-21       Impact factor: 5.640

5.  Amino Acid Nanofibers Improve Glycemia and Confer Cognitive Therapeutic Efficacy to Bound Insulin.

Authors:  Aejin Lee; McKensie L Mason; Tao Lin; Shashi Bhushan Kumar; Devan Kowdley; Jacob H Leung; Danah Muhanna; Yuan Sun; Joana Ortega-Anaya; Lianbo Yu; Julie Fitzgerald; A Courtney DeVries; Randy J Nelson; Zachary M Weil; Rafael Jiménez-Flores; Jon R Parquette; Ouliana Ziouzenkova
Journal:  Pharmaceutics       Date:  2021-12-29       Impact factor: 6.321
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.